Cargando…
Light at the end of the tunnel?: The Great Indian Pharmacoeconomics story
Autores principales: | Thakkar, Karan B., Billa, Gauri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862112/ https://www.ncbi.nlm.nih.gov/pubmed/24379781 http://dx.doi.org/10.3389/fphar.2013.00153 |
Ejemplares similares
-
Are trial participants adequately safeguarded by the ethics committees—the Indian scenario?
por: Thakkar, Karan, et al.
Publicado: (2014) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013) -
Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010) -
Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014) -
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
por: Huang, Hui-Yao, et al.
Publicado: (2020)